Note: Ingredients listed on restricted chemical lists
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
0.2-<0.9
EC/CAS
25322-68-3
Name of the chemical
polyethyleneglycol
Concentration
0.1-<0.3
EC/CAS
9003-39-8
Name of the chemical
polyvinylpyrrolidone
Concentration
3.88
General Information
Revision date
2021-01-12
Product name
ZEJULA TABLETS
Product Synonyms
NIRAPARIB TOSYLATE MONOHYDRATE, FORMULATED PRODUCT
Emergency telephone
+1-888-825-5249, +(1) 760 476 3971, +(1) 760 476 3962, +(1) 866 519 4752
Icons in SDS
Company Information
company name
GlaxoSmithKline US
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H302, H340, H361, H373, H410
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
Physical hazards
Not classified
Health hazards
Acute toxicity, oral Category 4 Germ cell mutagenicity Category 1B Reproductive toxicity Category 2 Specific target organ toxicity, repeated Category 2 exposure
Environmental hazards
Hazardous to the aquatic environment, Category 1
Signal word
Danger
Hazard statements
Harmful if swallowed. May cause genetic defects. Suspected of damaging fertility or the unborn child. May cause damage to organs through prolonged or repeated exposure. Very toxic to aquatic life with long lasting effects.
Prevention
Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Do not breathe dust/fume/gas/mist/vapors/spray. Wash hands thoroughly after handling. Do not eat, drink or smoke when using this product. Avoid release to the environment. Wear protective gloves/protective clothing/eye protection/face protection.
Response
If swallowed: Call a poison center/doctor/physician/ if you feel unwell. Rinse mouth. Immediately call a poison center/doctor/physician. Specific treatment is urgent (see information on this label). Collect spillage.
Storage
Store locked up.
Disposal
Dispose of contents/container in accordance with local/regional/national/international regulations. Hazard(s) not otherwise Caution - Potent pharmaceutical agent. See section 11 of the SDS for additional information on classified (HNOC) health hazards.
Additional information
34.995% of the mixture consists of component(s) of unknown acute oral toxicity. 99.565% of the mixture consists of component(s) of unknown acute dermal toxicity. 49.285% of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
2.1 Classification of the substance or mixture
Not classified. Health hazards Acute toxicity, oral Category 4 Germ cell mutagenicity Category 1B Reproductive toxicity Category 2 Specific target organ toxicity, repeated Category 2 exposure Environmental hazards Hazardous to the aquatic environment, Category 1 long-term hazard OSHA defined hazards Not classified.
